NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

數位療法 (DTx) :新時代的醫學

Digital Therapeutics: A New Age Medicine

出版商 BCC Research 商品編碼 930119
出版日期 內容資訊 英文 13 Pages
訂單完成後即時交付
價格
數位療法 (DTx) :新時代的醫學 Digital Therapeutics: A New Age Medicine
出版日期: 2020年03月20日內容資訊: 英文 13 Pages
簡介

本報告提供數位療法 (DTx) /數位治療市場相關調查,DTx市場新興市場相關概要及數位健康的發展趨勢相關討論,市場佔有率分析與傳統方法的比較,目前市場及市場潛在性,競爭環境、規定方案、成長要素、課題的相關分析等。

第1章 簡介

  • 調查目的
  • 調查理由
  • 調查範圍
  • 資訊來源
  • 分析師的經歷
  • BCC Research 相關報告

第2章 技術背景、市場動態

  • 概要
  • 數位療法 (DTx)的演進
  • 數位療法 (DTx)的優點
  • 市場動態
    • 市場成長要素
    • 市場課題

第3章 市售產品

第4章 競爭情形

  • 企業簡介
  • FLATIRON HEALTH INC.
  • LIVONGO HEALTH
  • LUMA HEALTH INC.
  • OVENTUS MEDICAL LTD.
  • SWORD HEALTH LDA
目錄
Product Code: HLC259A

Highlights:

The goal of this report is to understand the current digital therapeutics scenario and to assess the market’s growth potential. This study explores market dynamics that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market and the future direction of the market.

Report Includes

  • An overview of emerging market for digital therapeutics and discussion on their evolving trend in digital health
  • Detailed market share analysis of digital therapeutics and study their comparison with conventional methods
  • Highlights of current and future market potential and a detailed analysis of the competitive environment, regulatory scenario, and drivers, challenges, and trends affecting market growth
  • Coverage of new product innovations, launches, and rapid product advancements
  • The goals of this study were to understand the current digital therapeutics scenario and to assess the market’s growth potential. This study explores market dynamics that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market and the future direction of the market.

Report Scope:

The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. The report describes the factors driving the market and the challenges the market faces, and it also provides a market analysis at the global level. In addition, the report provides information regarding the trends in digital therapeutics in different countries. It also identifies the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further.

Report Includes:

  • An overview of emerging market for digital therapeutics and discussion on their evolving trend in digital health
  • Detailed market share analysis of digital therapeutics and study their comparison with conventional methods
  • Highlights of current and future market potential and a detailed analysis of the competitive environment, regulatory scenario, and drivers, challenges, and trends affecting market growth
  • Coverage of new product innovations, launches, and rapid product advancements

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of This Report
  • Information Sources
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Technology Background and Market Dynamics

  • Overview
  • Evolution of Digital Therapeutics
  • Benefits of Digital Therapeutics
  • Market Dynamics
    • Market Drivers
    • Market Challenges

Chapter 3: Market Products

Chapter 4: Competitive Landscape

  • Company Profiles
    • FLATIRON HEALTH INC.
    • LIVONGO HEALTH
    • LUMA HEALTH INC.
    • OVENTUS MEDICAL LTD.
    • SWORD HEALTH LDA

List of Tables

  • Table 1: Product Categories of Digital Therapeutics and Primary Purpose
  • Table 2: Global Digital Therapeutics Market, Through 2024
  • Table 3: Digital Therapeutics Company Funding Sources, 2017
  • Table 4: DTx Companies and Their Products
  • Table 5: Award Winning Companies in Digital Therapeutics-University of California, San Francisco (UCSF)